AIR645

DRUG2 trials

Sponsors

Altair Therapeutics, Inc.

Conditions

Asthma

Phase 1

A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma

CompletedNCT00658749

Altair Therapeutics, Inc.Asthma

Start: 2008-04-30End: 2009-05-31Updated: 2009-06-25

Phase 2

Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

CompletedNCT00941577

Altair Therapeutics, Inc.Asthma

Start: 2009-10-31End: 2010-06-30Updated: 2010-07-23